Pharmaceutical Flow Cytometry & Imaging 2016
Pharmaceutical Flow Cytometry & Imaging
The 5th biennial Pharmaceutical Flow Cytometry and Imaging meeting will be held at GlaxoSmithKline, Stevenage, UK. Flow cytometry and imaging are two powerful technology platforms that enable high-content analysis of physiologically-relevant cell systems and pre-clinical and clinical biomarkers. Since our first meeting in 2008, we have seen the technology develop and the applications widen across many areas of industrial and academic drug discovery and development. This meeting will focus on translational research in drug discovery and development, big data and analytics, novel and emerging technologies and next generation cytomics in pharmaceutical research.
We aim to bring together the research community working in the field of flow cytometry and imaging with interests in developing and applying the technology for pharmaceutical research. Join scientists from pharma, biotech, CROs and academia to hear talks given by speakers at the cutting edge of cytometry, take part in commercial vendor lab-based workshops, network at the exhibition, innovation forum and speakers dinner and gain strategic insights into solutions for increasing the success of drug discovery and development.
• Translational Flow Cytometry and Imaging in Drug Discovery and Development
New applications and strategies in target identification & validation, cell and gene therapy, immuno-oncology, drug safety, target engagement and dose selection, precision medicine and biopharmaceutical drug development.
• Big Data and Analytics
New Horizons in data management and analytical, statistical and modelling techniques relevant to analysis of high-dimensional and single cell cytometry and imaging data.
• Novel and Emerging Technologies
Next generation instrumentation, and probe and sensor technology for pharmaceutical research.
• Next generation Cytomics in Pharmaceutical Research
Exploration of the latest systems approaches, utilising functional genomic technologies to link the genome and proteome to cellular regulation and function, for predictive medicine.